Form D · Other Health Care
Select Pharma, LLC
Dallas, TX · CIK 0001627275
Offering snapshot reported Aug 22, 2016 · SEC filing
- Reported sold
- $84K Offering amount: $120K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $1.5K Reported outside-investor minimum
- First sale
- Apr 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2016 | Amendment | $84,000 | No comparison | 0 | SEC filing |
| Dec 5, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-229594
Source: Form D, filed Aug 22, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua James Daniel | Executive |
| Amir Darius Mortazavi | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
5710 Lbj Freeway Suite 165
Dallas, TX, 75240
Dallas, TX, 75240